Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer

Go back to Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial Officer
(NASDAQ: AKTX) Delayed: 8.24 +0.24 (3.00%)
Previous Close $8.00    52 Week High $19.75 
Open $8.50    52 Week Low $7.63 
Day High $8.97    P/E N/A 
Day Low $8.07    EPS $0.00 
Volume 45,801       

(NASDAQ: AKTX) Delayed: 8.24 +0.24 (3.00%)
Previous Close $8.00    52 Week High $19.75 
Open $8.50    52 Week Low $7.63 
Day High $8.97    P/E N/A 
Day Low $8.07    EPS $0.00 
Volume 45,801